In the past 18 months, numerous new classes of therapies have shown unprecedented activity in small cell lung cancer. T-cell engagers and antibody-drug conjugates are both largely new classes to small cell lung cancer-focused researchers and present novel challenges in terms of use, adverse event management, and translational research questions. This webinar will focus on application of these agents with unique toxicities and patient selection. 

This activity is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer including medical oncologists, thoracic surgeons, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician assistants.

Upon completion of this activity, the participants should be able to:

• Examine emerging T-cell engager and antibody-drug conjugate agents with activity in small cell lung cancer.
• Enhance management of toxicities associated with these drug classes.
• Evaluate translational knowledge gaps facing surface-targeting approaches in small cell lung cancer.

• Anne-Marie Dingemans, MD, PhD, Erasmus Medical Center, Rotterdam, The Netherlands
• Marina Baine, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
• Kathryn Simpson, PhD, CRUK National Biomarker Centre, CRUK Manchester Institute, Manchester, UK

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need any assistance with this activity, please email: education@iaslc.org.